|
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC |
61.33 |
|
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) |
31.36 |
|
Systematic discovery of endogenous human ribonucleoprotein complexes |
28.63 |
|
Cleavage Factor Im as a key regulator of 3’ UTR length |
25.56 |
|
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism |
25.15 |
|
RNA-seq analyses of human prostate cancer cells |
24.49 |
|
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines |
21.2 |
|
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons |
21.05 |
|
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment |
20.93 |
|
DART-seq: an antibody-free method for global m6A detection |
20.51 |
|
Transcriptomic analyssis following EHMT1/2 inhibition |
20.47 |
|
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD |
20.47 |
|
SLAM-seq for K562 endogenous mRNA decay |
18.95 |
|
Unique features and clinical importance of acute alloreactive immune responses |
17.43 |
|
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique |
17.08 |
|
IDH3a KO RNA-seq |
16.87 |
|
Identification of transcription start sites for human A549 cell line using ReCappable-seq |
16.19 |
|
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 |
16.02 |
|
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 |
15.9 |
|
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency |
15.8 |
|
Regulation of protein translation during mitosis |
15.69 |
|
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects |
15.56 |
|
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells |
15.52 |
|
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors |
15.26 |
|
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] |
14.57 |
|
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer |
14.57 |
|
Comprehensive comparative analysis of 5’ end RNA sequencing methods |
14.35 |
|
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors |
14.34 |
|
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription |
14.22 |
|
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression |
13.95 |
|
Oncogenic roles of ARID5B in T-ALL |
13.74 |
|
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex |
13.74 |
|
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq |
13.73 |
|
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells |
13.57 |
|
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors |
13.28 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA |
13.25 |
|
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer |
13.11 |
|
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP |
12.89 |
|
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms |
12.59 |
|
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response |
12.59 |
|
hnRNP C is a key regulator of protein synthesis in mitosis |
12.4 |
|
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas |
12.38 |
|
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. |
12.34 |
|
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer |
12.34 |
|
Tracking distinct RNA populations using efficient and reversible covalent chemistry |
12.27 |
|
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis |
12.15 |
|
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ |
12.11 |
|
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma |
11.99 |
|
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers |
11.96 |
|
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound |
11.95 |
|
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer |
11.91 |
|
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] |
11.91 |
|
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells |
11.57 |
|
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) |
11.5 |
|
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection |
11.5 |
|
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype |
11.39 |
|
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] |
11.39 |
|
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells |
11.35 |
|
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') |
11.35 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells |
11.2 |
|
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution |
11.07 |
|
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 |
10.89 |
|
MOF acetyl transferase regulates transcription and respiration in mitochondria |
10.84 |
|
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) |
10.52 |
|
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq |
10.43 |
|
Integrin signaling regulates YAP/TAZ to control skin homeostasis |
10.38 |
|
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 |
10.37 |
|
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer |
10.3 |
|
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) |
10.15 |
|
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells |
10.09 |
|
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state |
9.87 |
|
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection |
9.85 |
|
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures |
9.61 |
|
Patient-derived luminal breast cancer xenografts with progestins |
9.59 |
|
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins |
9.59 |
|
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control |
9.54 |
|
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome |
9.49 |
|
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells |
9.35 |
|
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells |
9.33 |
|
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] |
9.33 |
|
CRISPR adenine and cytosine base editors with reduced RNA off-target activities |
9.33 |
|
Transcription control by the ENL YEATS domain in acute leukemia |
9.23 |
|
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] |
9.23 |
|
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 |
8.99 |
|
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues |
8.97 |
|
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response |
8.88 |
|
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells |
8.87 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells |
8.84 |
|
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation |
8.8 |
|
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. |
8.79 |
|
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods |
8.78 |
|
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] |
8.69 |
|
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells |
8.69 |
|
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction |
8.61 |
|
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells |
8.59 |
|
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma |
8.55 |
|
Gene expression profile of LMSU gastric cancer cell p53 KO and KD |
8.55 |
|
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing |
8.51 |
|
Generating Patterned Kidney Organoids for Studying Development and Diseases |
8.49 |
|
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG |
8.36 |
|
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution |
8.34 |
|
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] |
8.34 |
|
CROP-Seq in Primary Human T Cells |
8.29 |
|
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. |
8.23 |
|
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy |
8.23 |
|
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository |
8.21 |
|
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells |
8.19 |
|
Global analysis of enhancer targets: Mosaic-seq |
8.18 |
|
Trans-differentiation of human adult peripheral blood T cells into neurons |
8.05 |
|
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation |
7.93 |
|
A transcriptome-wide divergence in protein translation scales with LIN28B expression |
7.92 |
|
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia |
7.86 |
|
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration |
7.82 |
|
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells |
7.81 |
|
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts |
7.81 |
|
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation |
7.8 |
|
Rorc disruption in human FG pancreatic cancer cells |
7.71 |
|
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia |
7.68 |
|
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development |
7.63 |
|
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 |
7.63 |
|
Wnt addiction of genetically defined cancers reversed by PORCN inhibition |
7.62 |
|
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes |
7.56 |
|
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) |
7.54 |
|
Expression by CD133+ cells isolated from the adult human exocrine pancreas |
7.51 |
|
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation |
7.5 |
|
HNF1A deficiency impairs β-cell fate, granule maturation and function |
7.46 |
|
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 |
7.46 |
|
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] |
7.46 |
|
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome |
7.44 |
|
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines |
7.4 |
|
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines |
7.37 |
|
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] |
7.37 |
|
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II |
7.28 |
|
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance |
7.22 |
|
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha |
7.21 |
|
ETV7 and interferon response |
7.21 |
|
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector |
7.14 |
|
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells |
7.11 |
|
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells |
7.06 |
|
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA |
7.01 |
|
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions |
7.01 |
|
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E |
7.0 |
|
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes |
6.94 |
|
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA |
6.94 |
|
Genetic disruption of COX-1 inhibits multiple oncogenic pathways |
6.91 |
|
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer |
6.86 |
|
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization |
6.85 |
|
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells |
6.74 |
|
Alu RNA modulates the expression of cell cycle genes in human fibroblasts |
6.69 |
|
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) |
6.64 |
|
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation |
6.63 |
|
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells |
6.58 |
|
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma |
6.57 |
|
Co-transcriptional loading of RNA export factors shapes the human transcriptome |
6.56 |
|
RNAseq of HEK293 cells after Chtop knockdown |
6.56 |
|
IGF2BP3 controls cancer cell invasiveness by modulation RISC function |
6.55 |
|
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression |
6.53 |
|
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome |
6.48 |
|
RNA-seq of RKO cells with cTAZ KO or putback |
6.46 |
|
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). |
6.42 |
|
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A |
6.4 |
|
RNA sequencing of primary human platelets and in vitro cell lines |
6.38 |
|
Lysine benzoylation is a novel histone mark |
6.33 |
|
Lysine benzoylation is a novel histone mark [RNA-seq] |
6.33 |
|
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO |
6.31 |
|
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] |
6.25 |
|
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D |
6.24 |
|
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks |
6.2 |
|
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. |
6.2 |
|
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons |
6.13 |
|
MicroRNA-125a-5p overexpression in human macrophages |
6.06 |
|
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML |
6.05 |
|
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation |
6.04 |
|
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks |
6.03 |
|
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells |
6.03 |
|
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 |
6.01 |
|
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) |
6.01 |
|
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium |
5.99 |
|
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 |
5.97 |
|
Direct Isolation and Characterization of Human Nephron Progenitors. |
5.89 |
|
Landscape and variation of RNA secondary structure across the human transcriptome |
5.88 |
|
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq |
5.88 |
|
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) |
5.86 |
|
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development |
5.82 |
|
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] |
5.82 |
|
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap |
5.81 |
|
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair |
5.81 |
|
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO |
5.79 |
|
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness |
5.77 |
|
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing |
5.76 |
|
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell |
5.76 |
|
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation |
5.61 |
|
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] |
5.61 |
|
Small-molecule targeting of brachyury transcription factor addiction in chordoma |
5.6 |
|
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] |
5.6 |
|
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice |
5.6 |
|
RNA-seq of resting and activated CD4+ T cells +-JQ1 |
5.53 |
|
Transcriptome landscape of HeLa response upon triamcinolone acetonide |
5.53 |
|
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) |
5.52 |
|
Genome-wide chromatin analysis of Ewing sarcoma |
5.52 |
|
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells |
5.49 |
|
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment |
5.49 |
|
A549 cells and MSR-A549 cells |
5.49 |
|
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment |
5.49 |
|
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation |
5.48 |
|
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA |
5.47 |
|
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes |
5.43 |
|
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets |
5.42 |
|
Transcriptomic analysis of human tonsillar TFH subsets |
5.4 |
|
Effect of CHKA knockdown on C4-2 cell transcriptome |
5.39 |
|
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. |
5.39 |
|
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. |
5.39 |
|
Modeling the MYC-driven normal-to-tumour switch in breast cancer. |
5.38 |
|
EWSR1 influences alternative splicing through direct and indirect mechanisms |
5.37 |
|
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA |
5.31 |
|
The cohesin complex prevents Myc-induced replication stress |
5.28 |
|
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing |
5.27 |
|
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. |
5.27 |
|
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries |
5.27 |
|
Single-cell analysis of adult human ovary using 10X genomics |
5.21 |
|
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression |
5.19 |
|
Effect of ILF3 on translation during homeostasis and the antiviral response |
5.19 |
|
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues |
5.18 |
|
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) |
5.18 |
|
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells |
5.18 |
|
N6-methyladenine DNA Modification in Glioblastoma |
5.1 |
|
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] |
5.1 |
|
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction |
5.09 |
|
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites |
5.09 |
|
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome |
5.04 |
|
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] |
5.04 |
|
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 |
5.04 |
|
RNA-seq analysis to identify the genes regulated by p53-SET interplay |
5.04 |
|
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] |
5.03 |
|
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture |
4.98 |
|
RNA-Seq with and without RNase treatment in PCa cell lines |
4.97 |
|
RNA sequencing of mechanically strained NHEKs and control NHEKs |
4.95 |
|
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium |
4.95 |
|
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells |
4.95 |
|
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells |
4.95 |
|
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] |
4.93 |
|
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells |
4.93 |
|
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol |
4.91 |
|
RNA editing in nascent RNA affects pre-mRNA splicing |
4.83 |
|
Total RNA-seq in ALL-SIL upon TLX1 knockdown |
4.79 |
|
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF |
4.77 |
|
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay |
4.75 |
|
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation |
4.75 |
|
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) |
4.72 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC |
4.71 |
|
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) |
4.7 |
|
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells |
4.7 |
|
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation |
4.69 |
|
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells |
4.68 |
|
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth |
4.66 |
|
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) |
4.58 |
|
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation |
4.56 |
|
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] |
4.56 |
|
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation |
4.55 |
|
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] |
4.51 |
|
Single-cell analysis of human kidney organoids |
4.5 |
|
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression |
4.5 |
|
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells |
4.5 |
|
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer |
4.45 |
|
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes |
4.44 |
|
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist |
4.41 |
|
O-glcnAc reprograms cellular energetics |
4.41 |
|
Effect of PRDM11 depletion in U2932 cells |
4.38 |
|
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) |
4.37 |
|
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. |
4.36 |
|
Solid phase chemistry to covalently and reversibly capture thiolated RNA |
4.34 |
|
Triple vectors expand AAV transfer capacity in the retina |
4.33 |
|
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] |
4.3 |
|
Iron response of HepG2 cells |
4.26 |
|
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. |
4.22 |
|
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment |
4.2 |
|
HEK293 Heat-shock experiment |
4.16 |
|
RNA-Seq of PRMT1 overexpression ECA109 cells |
4.16 |
|
Transcriptome sequencing of K-562 cells |
4.14 |
|
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches |
4.11 |
|
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors |
4.11 |
|
Effect of BB608 on Gene Expression in HNSCC Cell Line |
4.11 |
|
Positively selected enhancer elements endow tumor cells with metastatic competence |
4.1 |
|
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] |
4.07 |
|
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs |
4.04 |
|
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown |
4.01 |
|
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling |
4.0 |
|
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline |
3.99 |
|
FOXP3 protects conventional human T cells from premature restimulation-induced cell death |
3.97 |
|
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 |
3.97 |
|
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. |
3.96 |
|
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) |
3.96 |
|
The MEF2B Regulatory Network - RNA-seq data |
3.9 |
|
The MEF2B Regulatory Network |
3.9 |
|
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) |
3.88 |
|
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation |
3.88 |
|
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer |
3.85 |
|
mRNA expression profile of Lymphocytes |
3.84 |
|
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells |
3.83 |
|
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin |
3.83 |
|
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor |
3.75 |
|
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling |
3.74 |
|
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] |
3.73 |
|
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation |
3.67 |
|
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice |
3.64 |
|
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment |
3.64 |
|
Ribosome profiling upon inhibition of eIF4A |
3.64 |
|
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines |
3.62 |
|
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity |
3.62 |
|
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO |
3.61 |
|
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) |
3.59 |
|
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II |
3.58 |
|
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown |
3.56 |
|
Epigenetic reprogramming of melanoma cells by vitamin C treatment |
3.51 |
|
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance |
3.49 |
|
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis |
3.47 |
|
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis |
3.44 |
|
Transcriptional changes in lymphoma cells induced by LSD1 depletion |
3.44 |
|
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer |
3.44 |
|
RNA-sequencing in immortalized human mammary epithelial cells |
3.44 |
|
JunB control of keratinocyte-mediated inflammation [RNA-seq] |
3.43 |
|
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation |
3.43 |
|
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells |
3.38 |
|
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes |
3.38 |
|
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells |
3.36 |
|
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis |
3.32 |
|
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene |
3.31 |
|
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response |
3.22 |
|
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients |
3.21 |
|
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells |
3.19 |
|
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 |
3.14 |
|
p63 controls the enhancer landscape during keratinocyte differentiation |
3.13 |
|
Gene expression profile in breast cancer cells |
3.12 |
|
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells |
3.12 |
|
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies |
3.11 |
|
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] |
3.11 |
|
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood |
3.11 |
|
Gene expression changes caused by KRAS in MCF-10A |
3.08 |
|
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. |
3.08 |
|
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells |
3.07 |
|
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts |
3.07 |
|
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) |
3.07 |
|
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation |
3.07 |
|
RNA-seq data |
3.05 |
|
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells |
3.04 |
|
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition |
3.04 |
|
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block |
3.04 |
|
SLIGRL-induced gene expression changes in NHEK cells |
3.03 |
|
Peptidomimetic blockade of MYB in acute myeloid leukemia |
2.99 |
|
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] |
2.99 |
|
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) |
2.92 |
|
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) |
2.9 |
|
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] |
2.88 |
|
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses |
2.86 |
|
MCF-7 as a model for functional analysis of breast cancer risk variants |
2.84 |
|
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome |
2.82 |
|
Cystathionine-β-Synthase Promotes Colon Carcinogenesis |
2.78 |
|
Transcriptome of human keratinocytes with or without HPV16 oncogene expression |
2.78 |
|
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] |
2.78 |
|
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo |
2.76 |
|
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology |
2.73 |
|
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] |
2.71 |
|
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer |
2.71 |
|
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment |
2.69 |
|
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation |
2.68 |
|
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 |
2.63 |
|
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] |
2.6 |
|
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] |
2.59 |
|
PRDM1 inhibits proliferation of human colon cancer organoids |
2.57 |
|
The Genetic Landscape of Diamond-Blackfan Anemia |
2.52 |
|
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] |
2.46 |
|
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA |
2.45 |
|
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells |
2.43 |
|
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) |
2.43 |
|
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia |
2.43 |
|
Human cells contain natural double-stranded RNAs with potential regulatory capacity |
2.42 |
|
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] |
2.42 |
|
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer |
2.42 |
|
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] |
2.42 |
|
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells |
2.4 |
|
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity |
2.39 |
|
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs |
2.39 |
|
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy |
2.33 |
|
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas |
2.33 |
|
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs |
2.29 |
|
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression |
2.27 |
|
Regulation of hypoxia-inducible factor activity by ZMYND8 |
2.21 |
|
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] |
2.21 |
|
Real-time observation of light-controlled transcription in living cells |
2.18 |
|
Structure and degradation of circular RNAs regulate PKR activation in innate immunity |
2.16 |
|
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant |
2.15 |
|
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs |
2.12 |
|
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. |
2.03 |
|
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model |
1.99 |
|
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance |
1.93 |
|
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] |
1.93 |
|
Generation and persistence of human tissue-resident memory T cells in lung transplantation |
1.9 |
|
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] |
1.89 |
|
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers |
1.87 |
|
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles |
1.84 |
|
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation |
1.8 |
|
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration |
1.8 |
|
Transcriptional landscape changes during human embryonic stem cell derivation |
1.75 |
|
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing |
1.74 |
|
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape |
1.72 |
|
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene |
1.71 |
|
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues |
1.58 |
|
Chromatin landscape of human visceral and subcutaneous adipocytes |
1.56 |
|
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] |
1.54 |
|
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) |
1.54 |
|
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection |
1.49 |
|
Gene Expression Profiling of WT and KDM3A Knocked out Cell |
1.45 |
|
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells |
1.45 |
|
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. |
1.44 |
|
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling |
1.42 |
|
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) |
1.42 |
|
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu |
1.41 |
|
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown |
1.37 |
|
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs |
1.36 |
|
mRNA recovered upon RNF219 IP. [RNA-IP] |
1.35 |
|
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids |
1.35 |
|
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid |
1.35 |
|
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors |
1.31 |
|
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] |
1.3 |
|
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs |
1.28 |
|
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes |
1.24 |
|
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis |
1.24 |
|
SF3B1 Degron knockdown RNA-seq |
1.14 |
|
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] |
1.06 |
|
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. |
1.05 |
|
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs |
1.03 |
|
Unraveling cis-regulatory elements by mapping structural changes in mRNAs |
0.98 |
|
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs |
0.93 |
|
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line |
0.93 |
|
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease |
0.9 |
|
RNA seq with AML (NB4) cells upon FTO inhibition |
0.9 |
|
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies |
0.89 |
|
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 |
0.89 |
|
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 |
0.83 |
|
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) |
0.82 |
|
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness |
0.76 |
|
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells |
0.76 |
|
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down |
0.75 |
|
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation |
0.75 |
|
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis |
0.74 |
|
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells |
0.74 |
|
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation |
0.72 |
|
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue |
0.71 |
|
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO |
0.66 |
|
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing |
0.65 |
|
6mer seed toxicity in viral microRNAs |
0.61 |
|
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) |
0.59 |
|
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates |
0.59 |
|
single cell RNA-seq from GM12878 (ENCSR673UIY) |
0.59 |
|
siRNA-mediated knockdown |
0.57 |
|
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes |
0.56 |
|
Role of cervicovaginal microbiota in genital inflammation |
0.51 |
|
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. |
0.48 |
|
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. |
0.47 |
|
EGR1-controlled transcriptome of T HESCs |
0.44 |
|
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line |
0.43 |
|
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] |
0.42 |
|
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing |
0.4 |
|
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) |
0.37 |
|
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells |
0.37 |
|
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies |
0.36 |
|
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa |
0.36 |
|
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer |
0.33 |
|
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet |
0.33 |
|
Global transcriptome analysis of WT versus HEB-/- hESCs |
0.3 |
|
WNT signaling memory is required for ACTIVIN to function as a morphogen |
0.28 |
|
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer |
0.27 |
|
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line |
0.27 |
|
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes |
0.25 |
|
Myc activation coordinates gene transcription and protein translation responses |
0.25 |
|
Cell cycle dynamics of human pluripotent stem cells primed for differentiation |
0.24 |
|
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells |
0.24 |
|
Transcriptome profiling of A2M treated A549 Cell Line Samples |
0.24 |
|
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm |
0.22 |
|
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells |
0.22 |
|
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption |
0.21 |
|
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq |
0.19 |
|
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq |
0.19 |
|
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis |
0.19 |
|
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] |
0.19 |
|
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α |
0.15 |
|
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming |
0.14 |
|
Dermal endothelial cells of type 2 diabetic patients |
0.14 |
|
miRNAs affected by antagomiR-17 treatment |
0.12 |
|
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes |
0.1 |
|
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq |
0.09 |
|
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes |
0.09 |
|
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 |
0.08 |
|
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells |
0.07 |
|
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer |
0.07 |
|
p53 activity results in DNA replication fork processivity |
0.06 |
|
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit |
0.03 |
|
HEK293 TFAM Knockout Expression Study |
0.02 |
|
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis |
0.0 |
|
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] |
0.0 |